Log In
BCIQ
Print this Print this
 

HART-Trachea

  Manage Alerts
Collapse Summary General Information
Company Harvard Apparatus Regenerative Technology Inc.
DescriptionTransplant comprised of the patient's own bone marrow cells seeded on the company's porous plastic scaffolding in its InBreath organ bioreactor
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPreclinical
Standard IndicationTissue replacement
Indication DetailsRestore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection
Regulatory Designation U.S. - Orphan Drug (Restore the structure and/or function of the trachea subsequent to tracheal damage due to cancer, injury or infection)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today